BACKGROUND: Kidney transplant programs may avoid transplantation in obese patients because of reports indicating that obese patients have poorer outcomes than do nonobese patients. We recently reviewed our experience. METHODS: Patients receiving a kidney transplant between January 1, 1990 and December 31, 1999 were divided according to body mass index (BMI): group 1, BMI<25 (n=457); group 2, BMI> or =25 and <30 (n=278); and group 3, BMI> or =35 (n=98). RESULTS: Cadaveric graft survival rates at 2 years were 85% for group 1, 88% for group 2, and 85% for group 3 (P>0.10). Cadaveric patient survival rates at 2 years were 92% for group 1, 91% for group 2, and 94% for group 3 (P>0.10). There were no differences in technical losses or in posttransplantation wound complications. Group 3 patients, however, did have a higher incidence of steroid-induced posttransplantation diabetes mellitus than the other two groups (P<0.01). CONCLUSION: Obese transplant recipients have similar outcomes to nonobese patients.
BACKGROUND: Kidney transplant programs may avoid transplantation in obesepatients because of reports indicating that obesepatients have poorer outcomes than do nonobese patients. We recently reviewed our experience. METHODS:Patients receiving a kidney transplant between January 1, 1990 and December 31, 1999 were divided according to body mass index (BMI): group 1, BMI<25 (n=457); group 2, BMI> or =25 and <30 (n=278); and group 3, BMI> or =35 (n=98). RESULTS: Cadaveric graft survival rates at 2 years were 85% for group 1, 88% for group 2, and 85% for group 3 (P>0.10). Cadaveric patient survival rates at 2 years were 92% for group 1, 91% for group 2, and 94% for group 3 (P>0.10). There were no differences in technical losses or in posttransplantation wound complications. Group 3 patients, however, did have a higher incidence of steroid-induced posttransplantation diabetes mellitus than the other two groups (P<0.01). CONCLUSION:Obese transplant recipients have similar outcomes to nonobese patients.
Authors: Greg Knoll; Sandra Cockfield; Tom Blydt-Hansen; Dana Baran; Bryce Kiberd; David Landsberg; David Rush; Edward Cole Journal: CMAJ Date: 2005-11-08 Impact factor: 8.262
Authors: Krista L Lentine; Lisa A Rocca-Rey; Giuliana Bacchi; Nadia Wasi; Leslie Schmitz; Paolo R Salvalaggio; Kevin C Abbott; Mark A Schnitzler; Luca Neri; Daniel C Brennan Journal: Transplantation Date: 2008-07-27 Impact factor: 4.939
Authors: M Z Molnar; E Streja; C P Kovesdy; S Bunnapradist; M S Sampaio; J Jing; M Krishnan; A R Nissenson; G M Danovitch; K Kalantar-Zadeh Journal: Am J Transplant Date: 2011-04 Impact factor: 8.086
Authors: Elani Streja; Miklos Z Molnar; Csaba P Kovesdy; Suphamai Bunnapradist; Jennie Jing; Allen R Nissenson; Istvan Mucsi; Gabriel M Danovitch; Kamyar Kalantar-Zadeh Journal: Clin J Am Soc Nephrol Date: 2011-03-17 Impact factor: 8.237
Authors: Koosha Kamali; Mohammad Amin Abbasi; Ata Abbasi; Ahmad Mortazavi; Mohammad Hasan Seifee Journal: Indian J Surg Date: 2010-08-26 Impact factor: 0.656
Authors: Jeffrey Rogers; Kenneth D Chavin; Prabhakar K Baliga; Angello Lin; Osemwegie Emovon; Fuad Afzal; Elizabeth E Ashcraft; G Mark Baillie; David J Taber; P R Rajagopalan Journal: J Gastrointest Surg Date: 2003-12 Impact factor: 3.267